Methyl 2-aminothiazole-5-carboxylate

Catalog No.: 
ACCMNF035
CAS No.: 
6633-61-0
Molecular Formula: 
C5H6N2O2S
Molecular Weight: 
158.18
Methyl 2-aminothiazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g95%$65.00In stockInquiry
500g95%$308.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-aminothiazole-5-carboxylate
IUPAC Namemethyl 2-aminothiazole-5-carboxylate
MDL No.MFCD03788562
Molecular FormulaC5H6N2O2S
Molecular Weight158.18
SMILESC1=C(C(OC)=O)SC(=N1)N
InChI KeyUJNNCGWBDJHCEM-UHFFFAOYSA-N
SynonymMethyl 2-imino-2,3-dihydro-1,3-thiazole-5-carboxylate | BP-10836 | Methyl 2-imino-2,3-dihydrothiazole-5-carboxylate | 2-amino-5-carbomethoxy-thiazole | Methyl 2-amino-1,3-thiazole-5-carboxylate | SCHEMBL33099 | BBL102289 | FS-2685 | HMS3078M17 | MLS002608
CAS No.6633-61-0
PubChem CID238005

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCMNF035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMNF035 route product structure diagram
    ACCMNF0356633-61-0In Stock
Inquiry

2. ACCMNF035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMNF035 route product structure diagram
    ACCMNF0356633-61-0In Stock
Inquiry

3. ACCMNF035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCMNF035 route product structure diagram
    ACCMNF0356633-61-0In Stock
Inquiry

Comments (0)